OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Preventive Cardiology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
COP27 Climate Change Conference: urgent action needed for Africa and the world	531
Integrating lipoprotein(a) into preventive cardiology: probably important to get the measurement right	298
Anabolic steroids in athletes: the interplay of hormones and inflammation leading to the heart’s vulnerability	254
Does early initiation of non-statin therapy, evolocumab with LDL-C <50mg/dL contribute to the reduction of hospital readmissions in patients with ACS?: a single center real world evidence from	206
Cardiorespiratory fitness in relation to systolic and diastolic function in patients with heart failure and chronic coronary syndromes	184
Sex specific association of body composition with sphingosine-1-phosphate levels-results from the study of health in pomerania (SHIP) analysis	123
Characteristics and risk of coronary-related events following hospitalisation for chronic coronary disease	119
Evaluation of the age-related prevalence of cardiovascular risk factors to guide systematic long-term follow-up after preeclampsia	108
Exercise doppler Echocardiography of the right heart and pulmonary circulation in patients with cardiovascular risk factors: observations from the RIGHT Heart International NETwork (RIGHT-NET)	97
Temporal trends and outcomes of cardiac rehabilitation after acute coronary syndrome in an asian population	93
Statin therapy eligibility in a large primary prevention cohort according to European Society of Cardiology Guidelines	89
Sports-related sudden cardiac arrest: a video analysis of characteristics and outcomes	82
The role of the arrhythmologist in a sports cardiology centre: the devil is in the detail	80
Secondary prevention of Coronary Heart Disease (CHD) in the Moroccan population. Survey of Risk Factor (SURF) CHD II Morocco	79
Enhancement of left ventricular compliance in twin pregnancy	77
Genetic variants associated with cardiorespiratory symptoms of long COVID. The GINA-COVID study	76
Carotid intima-media thickness progression and plaque formation in recreational male endurance athletes - a 10-year follow-up study	72
Effects of a behavioral psychological intervention in addition to an exercise rehabilitation program in chronic heart failure patients	72
Association of cardiorespiratory fitness measured by cardiopulmonary exercise testing with covid-19 positivity: a prospective register-based cohort study	69
Effect of preventive training in cardiac transcriptoma in rats with pulmonary hypertension	67
Effect of hybrid cardiac rehabilitation using a smart device: a randomized controlled trial	66
Exercise cardiac magnetic resonance imaging in heart failure with preserved ejection fraction	65
Social networks as a predictor of cardiovascular disease incidence and mortality: 10-year observation of the Polish HAPIEE cohort	65
Modelling the long-term clinical outcomes of AI-enabled CCTA plaque quantification on preventive cardiovascular management	63
Cardiovascular rehabilitation - determinants of long-term outcomes	62

Differences in 10-year cardiovascular risk estimation using SCORE and SCORE2 risk prediction tools: a moderate risk country population analysis	62
Supraventricular tachycardia (SVT) and high troponin levels: patient characteristics and evaluation of coexisting coronary artery disease	59
Impact of type D personality on clinical outcomes in Spanish patients with myocardial infarction	57
Safety and efficacy of antiplatelet cessation after transcatheter patent foramen ovale closure	54
Women-focused cardiac rehabilitation delivery around the world and program enablers to support broader implementation	50
Prolonged troponin elevation after high-intensity exercise may indicate coronary artery disease	49
Effect of dapagliflozin on pro-oxidant/antioxidant balance and renal function in patients with diabetic kidney disease to reduce the risk of cardiovascular events	49
Risk stratification in chronic coronary syndrome: real-world application of SMART and EUROASPIRE scores for treatment optimization	48
Prognostic significance of non-ischemic computational pressure-flow dynamics derived fractional flow reserve in stable coronary artery disease patients in LAD versus non-LAD artery lesions	47
Clinical and instrumental follow-up and return to sport after surgical correction of anomalous origin of coronary arteries in young athletes	47
The importance of an individualized approach to risk assessment in Fontan patients considering pregnancy	46
Education training on physical activity in italian medical university courses: a call for action	46
LDL-C target attainment in the secondary prevention of atherosclerotic cardiovascular disease in Albania: barriers and strategies to reach the goals	46
RETRACTED AND REPLACED: Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease	45
Cardiovascular risk assessment in male and female patients with and without depression: an electronic health record evaluation in Wales	45
Respiratory vaccines as cardiovascular prevention: evidence from four landmark trials	44
Increasing pneumococcal vaccination in patients with heart failure: a scalable public health strategy	43
Prevalence of ventricular arrhythmias in apparently healthy workers: results from Ferrari Formula Benessere	43